GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of am I the only one who found API source harder than the injections — 22 comments in the full submission. View in context.
520
c/compounding·submitted 2 months ago by u/lukas_delgado

am I the only one who found API source harder than the injections

PSAbranch of 7 comments

Long-ish post, sorry. tl;dr at the bottom. I have been tracking telehealth against ApoB for 23 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…

Read the full submission and all 22 comments →

This branch

7 comments, started 2 months ago
u/lukas_delgado16 points·2 months ago

Disagree. What you are describing is consistent with 503B, not with what you concluded.

replysharereportpermalink
u/lukas_delgadoOP23 points·2 months ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/sofia_nascimento0 points·2 months ago

shortage list status is shortage list, check the actual list

replysharereportpermalink
u/bilal_osei1 point·2 months ago·edited

telehealth costs API source plus compounding markup, total varies

replysharereportpermalink
u/marit_laurent1 point·2 months ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/runa_grimaldi13 points·2 months ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/eu_apotheke_a17 points·2 months ago

Strongly agree. API source transparency matters.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →